{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:51:13Z","timestamp":1794739873032,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002644","name":"Pukyong National University","doi-asserted-by":"publisher","award":["202411620001"],"award-info":[{"award-number":["202411620001"]}],"id":[{"id":"10.13039\/501100002644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025IP0068"],"award-info":[{"award-number":["2025IP0068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171830"],"award-info":[{"award-number":["82171830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146783","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:15:02Z","timestamp":1754925302000},"page":"146783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Fucoidan from Durvillaea Antarctica elicits anticancer immunity against lung cancer via natural killer cell activation"],"prefix":"10.1016","volume":"322","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Koung","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseok","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-O","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146783_bb0005","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11101-022-09826-z","article-title":"Biological properties and potential of compounds extracted from red seaweeds","volume":"22","author":"Carpena","year":"2023","journal-title":"Phytochem. Rev."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146783_bb0010","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1080\/10408398.2021.1969534","article-title":"Seaweed polysaccharides: emerging extraction technologies, chemical modifications and bioactive properties","volume":"63","author":"Otero","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121555","article-title":"Opportunities and challenges of fucoidan for tumors therapy","volume":"324","author":"Yu","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146783_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/md20120755","article-title":"A review on fucoidan structure, extraction techniques, and its role as an immunomodulatory agent","volume":"20","author":"Jayawardena","year":"2022","journal-title":"Mar. Drugs"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.146783_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27186032","article-title":"Seaweeds in the oncology arena: anti-Cancer potential of Fucoidan as a drug-a review","volume":"27","author":"Jin","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146783_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ptr.7348","article-title":"Immunomodulatory effects of polysaccharides from marine algae for treating cancer, infectious disease, and inflammation","volume":"36","author":"Hwang","year":"2022","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146783_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/md21020112","article-title":"Fucoidan in pharmaceutical formulations: a comprehensive review for smart drug delivery systems","volume":"21","author":"Haggag","year":"2023","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146783_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/md19120678","article-title":"Anti-inflammatory mechanisms of fucoidans to treat inflammatory diseases: a review","volume":"19","author":"Sanjeewa","year":"2021","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146783_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/md22090401","article-title":"Anti-inflammatory effect of Fucoidan from Costaria costata inhibited lipopolysaccharide-induced inflammation in mice","volume":"22","author":"Zhang","year":"2024","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146783_bb0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/md21050302","article-title":"Fucoidan from Fucus vesiculosus inhibits inflammatory response, both in vitro and in vivo","volume":"21","author":"Wang","year":"2023","journal-title":"Mar. Drugs"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.146783_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179125","article-title":"Enhancement of immune checkpoint inhibitor-mediated anti-Cancer immunity by intranasal treatment of Ecklonia cava fucoidan against metastatic lung Cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijbiomac.2021.06.045","article-title":"Ecklonia cava fucoidan has potential to stimulate natural killer cells in vivo","volume":"185","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146783_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/md19050265","article-title":"The therapeutic potential of the anticancer activity of fucoidan: current advances and hurdles","volume":"19","author":"Jin","year":"2021","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146783_bb0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/md13031084","article-title":"Fucoidan from Macrocystis pyrifera has powerful immune-modulatory effects compared to three other fucoidans","volume":"13","author":"Zhang","year":"2015","journal-title":"Mar. Drugs"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146783_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099396","article-title":"Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses","volume":"9","author":"Jin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0080","article-title":"Antitumor and antioxidant activities of polysaccharides from the seaweed Durvillaea Antarctica","volume":"103","author":"A.D. Roberto","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146783_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/md20040223","article-title":"Purification, chemical characterization and immunomodulatory activity of a sulfated polysaccharide from marine brown algae Durvillaea Antarctica","volume":"20","author":"Qin","year":"2022","journal-title":"Mar. Drugs"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146783_bb0090","doi-asserted-by":"crossref","first-page":"10779","DOI":"10.3390\/ijms241310779","article-title":"Durvillaea Antarctica: a seaweed for enhancing immune and cardiometabolic health and gut microbiota composition modulation","volume":"24","author":"Guerrero-Wyss","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2025.146783_bb0095","article-title":"Fucoidan from Durvillaea Antarctica enhances the anti-cancer effect of anti-PD-L1 antibody by activating dendritic cells and T cells","volume":"280","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121899","article-title":"The STING-mediated antiviral effect of fucoidan from Durvillaea Antarctica","volume":"331","author":"Li","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117529","article-title":"Structural characterization and effect on leukopenia of fucoidan from Durvillaea Antarctica","volume":"256","author":"Yang","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"05","key":"10.1016\/j.ijbiomac.2025.146783_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/CM9.0000000000002991","article-title":"Recent advances and remaining challenges in lung cancer therapy","volume":"137","author":"Barr","year":"2024","journal-title":"Chin. Med. J."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146783_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168661","article-title":"Current and future development in lung cancer diagnosis","volume":"22","author":"Nooreldeen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146783_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12272-021-01312-y","article-title":"Mechanisms of resistance to chemotherapy in non-small cell lung cancer","volume":"44","author":"Min","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0130","article-title":"Clinical cancer immunotherapy: current progress and prospects","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146783_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cac2.12178","article-title":"Advancing to the era of cancer immunotherapy","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146783_bb0140","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146783_bb0145","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12026-017-8931-1","article-title":"Dendritic cell-based immunotherapy: a basic review and recent advances","volume":"65","author":"Constantino","year":"2017","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-immunol-101921-044122","article-title":"Designing cancer immunotherapies that engage T cells and NK cells","volume":"41","author":"Kyrysyuk","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146783_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12075","article-title":"Professional killers: the role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells","volume":"10","author":"Del Vecchio","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146783_bb0170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/14728222.2022.2161890","article-title":"Granzyme B as a therapeutic target: an update in 2022","volume":"26","author":"Aubert","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146783_bb0175","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/cancers13092184","article-title":"Natural killer\u2013dendritic cell interactions in liver cancer: implications for immunotherapy","volume":"13","author":"Cazzetta","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146783_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9111363","article-title":"The advantages and challenges of anticancer dendritic cell vaccines and NK cells in adoptive cell immunotherapy","volume":"9","author":"Abakushina","year":"2021","journal-title":"Vaccines"},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.146783_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202302825","article-title":"Artificial immunogenic cell death lipid nanoparticle functions as a therapeutic vaccine for cancer","volume":"33","author":"Kim","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146783_bb0190","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood-2004-01-0380","article-title":"NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs","volume":"104","author":"Borg","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/md23010038","article-title":"Polysaccharide fraction isolated from Saccharina japonica exhibits anti-Cancer effects through Immunostimulating activities","volume":"23","author":"Park","year":"2025","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146783_bb0200","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1073\/pnas.1118834109","article-title":"Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity","volume":"109","author":"Lang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S439969","article-title":"CD69 is a promising immunotherapy and prognosis prediction target in cancer","author":"Li","year":"2024","journal-title":"ImmunoTargets and therapy"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.146783_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246203","article-title":"Natural products\/bioactive compounds as a source of anticancer drugs","volume":"14","author":"Asma","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0215","series-title":"Bioactive natural products for pharmaceutical applications","author":"Pal","year":"2021"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146783_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering9090472","article-title":"Fucoidan from marine macroalgae: biological actions and applications in regenerative medicine, drug delivery systems and food industry","volume":"9","author":"Anisha","year":"2022","journal-title":"Bioengineering"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0225","doi-asserted-by":"crossref","DOI":"10.1080\/15502783.2023.2224751","article-title":"Effects of fucoidan supplementation on inflammatory and immune response after high-intensity exercise","volume":"20","author":"McFadden","year":"2023","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"10.1016\/j.ijbiomac.2025.146783_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijbiomac.2022.03.122","article-title":"Comparison of the immune activation capacities of fucoidan and laminarin extracted from Laminaria japonica","volume":"208","author":"An","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"8000","key":"10.1016\/j.ijbiomac.2025.146783_bb0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146783_bb0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146783_bb0245","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/md18080376","article-title":"Molecular targets and related biologic activities of fucoidan: a review","volume":"18","author":"Lin","year":"2020","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146783_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025073404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025073404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:44:15Z","timestamp":1779770655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025073404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S0141813025073404"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146783","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fucoidan from Durvillaea Antarctica elicits anticancer immunity against lung cancer via natural killer cell activation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146783"}}